Skip to contentSkip to filters

We use cookies for analytics.

Topic: AMPA receptors

ePoster
3 ePosters
Seminar
1 seminar

In Computational Neuroscience and Neuroscience

Seminar · Brain Imaging

Use of brain imaging data to improve prescriptions of psychotropic drugs - Examples of ketamine in depression and antipsychotics in schizophrenia

Xenia Marlene HART. · Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany & Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan

Fri, Oct 13, 2023 · 11:00 UTC

The use of molecular imaging, particularly PET and SPECT, has significantly transformed the treatment of schizophrenia with antipsychotic drugs since the late 1980s. It has offered insights into the links between drug target engagement, clinical effects, and side effects. A therapeutic window for receptor occupancy is established for antipsychotics, yet there is a divergence of opinions regarding the importance of blood levels, with many downplaying their significance. As a result, the role of therapeutic drug monitoring (TDM) as a personalized therapy tool is often underrated. Since molecular

ePoster · Neuroscience

Homeostatic regulation through aggregate synaptic dynamics at multiple timescales

Petros Vlachos, Jochen Triesch · Bernstein Conference 2024

Synaptic changes driven by Hebbian plasticity are unstable and require compensatory mechanisms to homeostatically control neuronal activity. Synaptic scaling regulates the synaptic efficacies to bring individual neurons to a set firing regime [1]. However, the timescales of synaptic scaling are too slow to counterbalance the rapid growth due to Hebbian mechanisms [2]. Heterosynaptic plasticity that operates on timescales similar to Hebbian processes can prevent runaway potentiation [3] but its ability to homeostatically control activity is uncertain. Here, we introduce aggregate scaling, a si

ePoster · Neuroscience

Unifying fast and slow temporal dynamics of AMPARs during Long-Term Potentiation

Surbhit Wagle, Nataliya Kraynyukova, Maximilian Kracht, Anne-Sophie Hafner, Amparo Acker-Palmer, Erin Schuman, Tatjana Tchumatchenko · Bernstein Conference 2024

AMPA receptors (AMPARs) mediate fast excitatory neurotransmission and participate in memory formation. Synaptic strength is proportional to the number of AMPARs in the postsynaptic membrane. Previous models of AMPA receptor trafficking can explain their fast, brief incorporation in dendritic spines after LTP induction but offer limited insights into long-lasting changes in AMPAR content at potentiated spines[1,2]. Hence, a unified modeling framework is necessary to understand persistent synaptic changes in AMPAR numbers. Molecular trafficking, such as diffusion, active transport, endo/exocytos

ePoster · Neuroscience

Investigation of N-acetyl spermine mechanism of action in an ex vivo model of human brain neocortex and its use as a potential antiseizure medication compound

Alice Podestà, Laura Monni, Thilo Kalbhenn, Matthias Simon, Ran Xu, Julia Onken, Ulrich-Wilhelm Thomale, Henrik Alle, Dietmar Schmitz, Martin Holtkamp, Jörg Geiger, Pawel Fidzinski · FENS Forum 2024

N-acetyl spermine (NASPM) is known from in vitro and in vivo animal models for its action as calcium permeable AMPA receptors (CP-AMPARs) antagonist. Our study aim to investigate the impact of NASPM on an ex vivo human brain slice neocortex model, focusing on its ability to suppress epileptic activity. While AMPA receptors play a central role in neocortical signaling and neuronal activity, the contribution of CP-AMPARs, particularly in the context of seizure-induced inhibition/excitation imbalance, remains unknown. By applying NASPM to ex vivo human cortex slices, we aimed to investigate its a